Jamison Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24M Buy
20,014
+110
+0.6% +$112K 2.42% 7
2026
Q1
$18.3M Sell
19,904
-801
-4% -$812K 2.23% 9
2025
Q4
$22.3M Sell
20,705
-193
-0.9% -$185K 2.7% 4
2025
Q3
$15.9M Buy
20,898
+14
+0.1% +$10.4K 2.02% 11
2025
Q2
$16.3M Buy
20,884
+5
+0% +$3.88K 2.34% 6
2025
Q1
$17.2M Sell
20,879
-784
-4% -$652K 2.63% 6
2024
Q4
$16.7M Buy
21,663
+159
+0.7% +$132K 2.47% 6
2024
Q3
$19.1M Buy
21,504
+28
+0.1% +$25.2K 2.9% 6
2024
Q2
$19.4M Sell
21,476
-427
-2% -$342K 3.23% 6
2024
Q1
$17M Sell
21,903
-164
-0.7% -$117K 2.88% 6
2023
Q4
$12.9M Sell
22,067
-329
-1% -$192K 2.41% 5
2023
Q3
$12M Buy
+22,396
New +$11.5M 2.49% 5

Other funds holding LLY

Jamison Private Wealth Management's LLY Position: Q2 2026 in Review

Jamison Private Wealth Management increased its Eli Lilly (LLY) stake by 0.55% in Q2 2026, buying an estimated $112K and bringing the position to 20,014 shares worth $24M. The position accounts for 2.42% of the portfolio, ranked #7.

Jamison Private Wealth Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jamison Private Wealth Management held 20,014 shares of Eli Lilly worth $24M as of Q2 2026.
  • Jamison Private Wealth Management bought 110 Eli Lilly shares in Q2 2026, an estimated $112K.
  • Eli Lilly made up 2.42% of Jamison Private Wealth Management's portfolio in Q2 2026, its #7 holding.
  • Jamison Private Wealth Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jamison Private Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.